16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Clinical trial NCT01948791 · COMPLETED
Trial details
- NCT number
- NCT01948791
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-09-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.